glp 1 va coverage The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Coverage of Obesity Therapies in

The organization has encouraged the company to study serious conditions, such as stroke, heart attack, and liver injury that may be drug-related

Find easy, protein-rich recipes, expert tips from our in-house nutritionist, and wellness resources that support your journeymind, body, and soul

Many employees find it hard to concentrate on their daily work when living paycheck to paycheck, struggling to pay the bills, and feeling anxious about affording a comfortable retirement

weight loss at target dose (trial data) ~21% (SURMOUNT) CV risk reduction labelled Under study Format Prefilled KwikPen + single-dose autoinjector India price (May 2026) 14,00027,500/month DCGI-approved Yes (March 2025) Generic competition in India No no Indian biosimilar yet Weight-loss percentages are trial averages at target dose individual response varies